Patent Expiry
XFOR: XOLREMDI: recorded patent 11045461 expiry
December 11, 2038 · MAVORIXAFOR. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 11, 2038
- Company
- X4 Pharmaceuticals, Inc (XFOR)
- Drug
- MAVORIXAFOR
BioSniper AIPage context preserved
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
XOLREMDI: recorded patent 11045461 expiry
Orange Book application NDA218709, product 001, listed patent 11045461 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- MAVORIXAFOR